Reminder: If you're still within your first 8 to 12 weeks or havent reached your full therapeutic dose, its likely too early to judge your progress
The development of obesity is rarely due to a single cause
Comparing Early Dosing vs
The FDA does not consider a drug product to be commercially available, however, if it has been discontinued and is no longer marketed, or if the drug appears on the FDA drug shortage list, such as Wegovy
With GLP-1 identified, researchers immediately recognized its therapeutic potential: if one could harness GLP-1s potent glucose-lowering and appetite-suppressing effects , it might become a treatment for diabetes or even obesity
Our medical team provides clear instructions on the correct administration technique and treatment schedule to help you achieve the best possible results